Seer, Inc. (SEER)

Market Cap	146.42M
Revenue (ttm)	16.62M
Net Income (ttm)	-93.90M
Shares Out	63.94M
EPS (ttm)	-1.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220,543
Open	2.28
Previous Close	2.27
Day's Range	2.26 - 2.32
52-Week Range	2.25 - 8.78
Beta	1.42
Analysts	Sell
Price Target	8.25 (+260.26%)
Earnings Date	Nov 7, 2023

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and b...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 164
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER

Financial Performance

In 2022, Seer, Inc.'s revenue was $15.49 million, an increase of 134.14% compared to the previous year's $6.62 million. Losses were -$92.97 million, 30.6% more than in 2021.

Analyst Forecast

According to 2 analysts, the average rating for SEER stock is "Sell." The 12-month stock price forecast is $8.25, which is an increase of 260.26% from the latest price.

Price Target

$8.25

(260.26% upside)

Analyst Consensus: Sell